DeepMed Research

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

ISCHEMIA-EXTEND (Extended Follow-up)

Active, not recruiting

Conditions: Cardiovascular Diseases
Coronary Artery Disease
Heart Diseases
Myocardial Ischemia
Coronary Disease

Interventions: Procedure: cardiac catheterization
Behavioral: Lifestyle
Procedure: coronary artery bypass graft surgery
Drug: Medication
Procedure: percutaneous coronary intervention

First Posted Date: 2021-05-20

Last Posted Date: 2025-03-26

Lead Sponsor: NYU Langone Health

Target Recruit Count: 5391

Registration Number: NCT04894877

Optimized MRI of Patients With Hip Arthroplasty

Not Applicable

Recruiting

Conditions: Hip Arthropathy

Interventions: Device: Modified MRI

First Posted Date: 2021-05-06

Last Posted Date: 2025-04-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 22

Registration Number: NCT04875884

Locations: 🇺🇸
NYU Langone Radiology - Center for Biomedical Imaging, New York, New York, United States

Electronic Triggers: Messaging After A1C EHR Alert

Completed

Conditions: Hemoglobins
Diagnostic Tests

Interventions: Behavioral: MyChart message

First Posted Date: 2021-05-03

Last Posted Date: 2024-04-10

Lead Sponsor: NYU Langone Health

Target Recruit Count: 2403

Registration Number: NCT04869319

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Pecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis

Phase 4

Completed

Conditions: Tendonitis

Interventions: Drug: Bupivacaine 20mL 0.5%
Drug: Bupivacaine up to 15mL 0.25%
Drug: Bupivacaine 20mL 0.25%

First Posted Date: 2021-04-30

Last Posted Date: 2024-12-13

Lead Sponsor: NYU Langone Health

Target Recruit Count: 160

Registration Number: NCT04867369

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity

Not Applicable

Recruiting

Conditions: Children With Medical Complexity (CMC)

Interventions: Behavioral: HELPix Care Plan

First Posted Date: 2021-04-30

Last Posted Date: 2025-02-26

Lead Sponsor: NYU Langone Health

Target Recruit Count: 282

Registration Number: NCT04867395

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Couples Lived Experience

Recruiting

Conditions: Alzheimer Disease
Dementia of Alzheimer Type

First Posted Date: 2021-04-28

Last Posted Date: 2025-04-17

Lead Sponsor: NYU Langone Health

Target Recruit Count: 600

Registration Number: NCT04863495

Locations: 🇺🇸
Boston University, Bedford, Massachusetts, United States
🇺🇸
NYU Langone Health, New York, New York, United States

Use of the Napoleon to Improve Polyp Measurement in Gastroenterology Fellows

Early Phase 1

Active, not recruiting

Conditions: Colonic Polyp

Interventions: Other: Visual estimation of polyp size
Other: Napoleon measurement of polyp size

First Posted Date: 2021-04-26

Last Posted Date: 2025-04-20

Lead Sponsor: NYU Langone Health

Target Recruit Count: 46

Registration Number: NCT04858477

Locations: 🇺🇸
NYU Langone Hospital Brooklyn, Brooklyn, New York, United States
🇺🇸
Bellevue Hospital Center, New York, New York, United States
🇺🇸
Manhattan VA Medical Center, New York, New York, United States

and more 1 locations

Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Ocrelizumab

First Posted Date: 2021-04-22

Last Posted Date: 2023-06-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 122

Registration Number: NCT04855617

Locations: 🇺🇸
Elliot Lewis Center for Multiple Sclerosis Care, Wellesley, Massachusetts, United States
🇺🇸
NYU Langone Health Multiple Sclerosis Comprehensive Care Center (NYULH MSCCC), New York, New York, United States

Vaccine-generated Immunity in Ocrelizumab-treated Patients: Longitudinal Assessments (VIOLA)

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: SARS-COV-2 mRNA Vaccine

First Posted Date: 2021-04-14

Last Posted Date: 2023-11-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 64

Registration Number: NCT04843774

Locations: 🇺🇸
University of Colorado, Denver (UCD), Denver, Colorado, United States
🇺🇸
NYU Langone Health Multiple Sclerosis Comprehensive Care Center (NYULH MSCCC), New York, New York, United States

Effect of Postoperative Single Dose of Ketamine on Pain After Mastectomy

Phase 4

Completed

Conditions: Postoperative Pain

Interventions: Drug: Ketamine
Drug: Placebo

First Posted Date: 2021-04-05

Last Posted Date: 2023-05-16

Lead Sponsor: NYU Langone Health

Target Recruit Count: 31

Registration Number: NCT04831736

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy